• market

  PRIVATE

• industry

  Biotechnology

• website

  immunomedics.com

• crunchbase

  immunomedics

Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. It was acquired by Gilead Sciences in October 2020.